US2002107214A1PendingUtilityA1
Gene repair involving the induction of double-stranded DNA cleavage at a chromosomal target site
Est. expiryFeb 3, 2019(expired)· nominal 20-yr term from priority
C07K 2319/00C12N 15/902C12N 9/22C12N 2800/80A61K 48/00C07K 2319/03C12N 15/907A61P 43/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of modifying, repairing, attenuating and inactivating a gene or other chromosomal DNA in a cell are disclosed. Also disclosed are methods of treating or prophylaxis of a genetic disease in an individual in need thereof. Further disclosed are chimeric restriction endonucleases.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of repairing a specific sequence of interest in chromosomal DNA of a cell comprising the steps of:
(a) inducing in the cell double stranded cleavage at a site of interest using a chimeric restriction endonuclease, said chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain; and (b) introducing targeting DNA into the cell under conditions appropriate for introduction of the targeting DNA into the site of interest, wherein said targeting DNA comprises (1) DNA homologous to the region surrounding the site of interest and (2) DNA which repairs the specific sequence of interest upon recombination between said targeting DNA and the chromosomal DNA.
2 . The method of claim 1 wherein the specific sequence of interest is a mutation.
3 . The method of claim 1 wherein the DNA binding sequence is a zinc finger binding domain.
4 . The method of claim 1 wherein the DNA binding sequence is a meganuclease recognition site.
5 . The method of claim 1 wherein the DNA cleavage domain is a restriction endonuclease cleavage domain.
6 . The method of claim 4 wherein the meganuclease recognition site is a I-SceI recognition site and the DNA cleavage domain is the FokI cleavage domain.
7 . A method of modifying a specific sequence in chromosomal DNA of a cell comprising the steps of:
(a) inducing in the cell double stranded cleavage at a site of interest in the specific sequence to be modified using a chimeric restriction endonuclease, said chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain; and (b) introducing targeting DNA into the cell under conditions appropriate for introduction of the targeting DNA into the site of interest, wherein said targeting DNA comprises (1) DNA homologous to the region surrounding the site of interest and (2) DNA which modifies the specific sequence upon recombination between said targeting DNA and the chromosomal DNA.
8 . The method of claim 7 wherein the DNA binding sequence is a zinc finger binding domain.
9 . The method of claim 7 wherein the DNA binding sequence is a meganuclease recognition site.
10 . The method of claim 7 wherein the DNA cleavage domain is a restriction endonuclease cleavage domain.
11 . The method of claim 9 wherein the meganuclease recognition site is a I-SceI recognition site and the DNA cleavage domain is the FokI cleavage domain.
12 . A method of attenuating an endogenous gene of interest in a cell comprising the steps of:
(a) inducing in the cell double stranded cleavage at a site of interest in the endogenous gene of interest using a chimeric restriction endonuclease, said chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain; and (b) introducing targeting DNA into the cell under conditions appropriate for introduction of the targeting DNA into the site of interest, wherein said targeting DNA comprises (1) DNA homologous to the region surrounding the site of interest and (2) DNA which attenuates the gene of interest upon recombination between said target DNA and the gene of interest.
13 . The method of claim 12 wherein the DNA binding sequence is a zinc finger binding domain.
14 . The method of claim 12 wherein the DNA binding sequence is a meganuclease recognition site.
15 . The method of claim 12 wherein the DNA cleavage domain is a restriction endonuclease cleavage domain.
16 . The method of claim 14 wherein the meganuclease recognition site is a I-SceI recognition site and the DNA cleavage domain is the FokI cleavage domain.
17 . A method of introducing a mutation into a site of interest in of chromosomal DNA of a cell comprising the steps of:
(a) inducing in the cell double stranded cleavage at the site of interest using a chimeric restriction endonuclease, said chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain; and (b) introducing targeting DNA into the cell under conditions appropriate for introduction of the targeting DNA into the site of interest, wherein said targeting DNA comprises (1) DNA homologous to the region surrounding the site of interest and (2) the mutation to be introduced into the site of interest.
18 . The method of claim 17 wherein the DNA binding sequence is a zinc finger binding domain.
19 . The method of claim 17 wherein the DNA binding sequence is a meganuclease recognition site.
20 . The method of claim 17 wherein the DNA cleavage domain is a restriction endonuclease cleavage domain.
21 . The method of claim 19 wherein the meganuclease recognition site is a I-SceI recognition site and the DNA cleavage domain is the FokI cleavage domain.
22 . A method for treating or prophylaxis of a genetic disease in an individual in need thereof comprising the steps of:
(a) inducing in cells of the individual double stranded cleavage at a site of interest using a chimeric restriction endonuclease, said chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain; and (b) introducing targeting DNA into the individual under conditions appropriate for introduction of the targeting DNA into the site of interest, wherein said targeting DNA comprises (1) DNA homologous to the region surrounding the site of interest and (2) DNA which repairs the site of interest upon recombination between the targeting DNA and the chromosomal DNA.
23 . The method of claim 22 wherein the DNA binding sequence is a zinc finger binding domain.
24 . The method of claim 22 wherein the DNA binding sequence is a meganuclease recognition site.
25 . The method of claim 22 wherein the DNA cleavage domain is a restriction endonuclease cleavage domain.
26 . The method of claim 24 wherein the meganuclease recognition site is a I-SceI recognition site and the DNA cleavage domain is the FokI cleavage domain.
27 . A method for treating or prophylaxis of a genetic disease in an individual in need thereof comprising inducing in cells of the individual double stranded cleavage at a site of interest using a chimeric restriction endonuclease, said chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain, under conditions appropriate for chromosomal DNA homologous to the region surrounding the site of interest to be introduced into the site of interest and repair of the site of interest.
28 . The method of claim 27 wherein the DNA binding sequence is a zinc finger binding domain.
29 . The method of claim 27 wherein the DNA binding sequence is a meganuclease recognition site.
30 . The method of claim 27 wherein the DNA cleavage domain is a restriction endonuclease cleavage domain.
31 . The method of claim 29 wherein the meganuclease recognition site is a I-SceI recognition site and the DNA cleavage domain is the FokI cleavage domain.
32 . A method of correcting a genetic lesion in chromosomal DNA of a cell comprising inducing in the cell double stranded cleavage at a site of interest in the genetic lesion using a chimeric restriction endonuclease, said chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain, under conditions appropriate for chromosomal DNA homologous to the region surrounding the site of interest to be introduced into the site of interest and correction of the genetic lesion.
33 . The method of claim 32 wherein the DNA binding sequence is a zinc finger binding domain.
34 . The method of claim 32 wherein the DNA binding sequence is a meganuclease recognition site.
35 . The method of claim 32 wherein the DNA cleavage domain is a restriction endonuclease cleavage domain.
36 . The method of claim 34 wherein the meganuclease recognition site is a I-SceI recognition site and the DNA cleavage domain is the FokI cleavage domain.
37 . A method of modifying a specific sequence in chromosomal DNA of a cell comprising inducing in the cell double stranded cleavage at a site of interest in the specific sequence to be modified using a chimeric restriction endonuclease, said chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain, under conditions appropriate for chromosomal DNA homologous to the region surrounding the site of interest to be introduced into the site of interest and modification of the specific sequence.
38 . The method of claim 37 wherein the DNA binding sequence is a zinc finger binding domain.
39 . The method of claim 37 wherein the DNA binding sequence is a meganuclease recognition site.
40 . The method of claim 37 wherein the DNA cleavage domain is a restriction endonuclease cleavage domain.
41 . The method of claim 39 wherein the meganuclease recognition site is a I-SceI recognition site and the DNA cleavage domain is the FokI cleavage domain.
42 . A method of repairing a specific sequence of interest in chromosomal DNA of a cell comprising inducing in the cell double stranded cleavage at a site of interest using a chimeric restriction endonuclease, said chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain, under conditions appropriate for chromosomal DNA homologous to the region surrounding the site of interest to be introduced into the site of interest and repair of the specific sequence of interest.
43 . The method of claim 42 wherein the specific sequence of interest is a mutation.
44 . The method of claim 42 wherein the DNA binding sequence is a zinc finger binding domain.
45 . The method of claim 42 wherein the DNA binding sequence is a meganuclease recognition site.
46 . The method of claim 42 wherein the DNA cleavage domain is a restriction endonuclease cleavage domain.
47 . The method of claim 45 wherein the meganuclease recognition site is a I-SceI recognition site and the DNA cleavage domain is the FokI cleavage domain.
48 . A chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain.
49 . The chimeric restriction endonuclease of claim 48 wherein the DNA binding sequence is a zinc finger binding domain.
50 . The chimeric restriction endonuclease of claim 48 wherein the DNA binding sequence is a meganuclease recognition site.
51 . The chimeric restriction endonuclease of claim 48 wherein the DNA cleavage domain is a restriction endonuclease cleavage domain.
52 . The chimeric restriction endonuclease of claim 50 wherein the meganuclease recognition site is a I-SceI recognition site and the DNA cleavage domain is the FokI cleavage domain.Join the waitlist — get patent alerts
Track US2002107214A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.